Ouro Medicines, a biotechnology company developing immune reset therapeutics for people living with chronic, immune-mediated ...
Please provide your email address to receive an email when new articles are posted on . A “complete eradication” of B cells with chimeric antigen receptor T-cell therapy is responsible for the ...
Researchers at The University of Osaka have discovered precursor T follicular regulatory cells (preTfr), comprising 30-50% of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback